Imexpharm

Chinese company spends over 6 trillion VND to acquire Imexpharm pharmaceutical company.

Báo Thanh niên

12/05/2026

Imexpharm launches a solution to support the treatment of musculoskeletal diseases.

Báo Đầu tư

28/12/2025

Decoding Imexpharm's High Growth Drivers in 2025

Báo Đầu tư

18/02/2025

CSA 2025 honors Imexpharm: A lasting legacy for the community and a green planet.

Báo Đầu tư

29/12/2024

Imexpharm ranked #1 best workplace in Vietnam in 2024.

Báo Đầu tư

01/12/2024

SK representative holds the position of Chairman of the Board of Directors of Imexpharm.

Báo Đầu tư

04/11/2024

The challenge is finding a company capable of leading the domestic pharmaceutical industry.

Việt Nam

30/10/2024

Imexpharm announces its business results for the third quarter and the first nine months of 2024.

Việt Nam

22/10/2024

Imexpharm Pharmaceuticals shows impressive growth.

VietNamNet

22/10/2024

By boosting R&D, Imexpharm hopes to gain a foothold in the global pharmaceutical supply chain.

Báo Thanh niên

16/10/2024

Imexpharm finalizes stock bonus at a 1:1 ratio.

Báo Đầu tư

14/09/2024

Imexpharm Pharmaceuticals is about to issue bonus shares at a ratio of 1:1.

Báo Đầu tư

04/09/2024

Imexpharm (IMP) reports a decline in profits and expects to pay a dividend of 20%.

Công Luận

30/06/2024

Pack fever-reducing medication for your travels.

Báo Tuổi Trẻ

23/05/2024

Setting a revenue target of 2.63 trillion VND, considering investing in a new factory.

Báo Đầu tư

30/04/2024

Imexpharm's stock rebounded after the release of its financial statements.

Người Đưa Tin

19/10/2023

Pharmaceutical giants 'clear out inventory', planning for the long term.

VietNamNet

22/06/2023